Why did HIMS's earnings growth slow in Q4 2024?

Hims & Hers Health, Inc. (HIMS) experienced a significant revenue growth rate of 95.09% in Q4 2024, which is a substantial increase in the company's top-line earnings. Therefore, the notion of a slowdown in earnings growth does not seem to align with the available financial data. |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |HIMS|HIMS.N|Hims & Hers Health|2024 Q1|45.81485558525974|2.78171E8|169| |HIMS|HIMS.N|Hims & Hers Health|2024 Q2|51.81807687867944|3.15648E8|169| |HIMS|HIMS.N|Hims & Hers Health|2024 Q3|77.13179149444859|4.01556E8|169| |HIMS|HIMS.N|Hims & Hers Health|2024 Q4|95.09405195868932|4.81139E8|169| However, if we consider the term "earnings growth" to encompass not only revenue but also profit margins, the scenario appears more nuanced. The company's net margin was reported to be negative at -0.24%. This indicates that for every dollar of revenue, the company incurred a loss of 0.24 cents. Moreover, the return on equity was also negative at -0.70%. These metrics suggest that while revenue was growing, the company's profitability was under pressure, which could be interpreted as a slowdown in earnings growth in terms of profitability. The negative net margin and return on equity could be attributed to various factors such as increased operational costs, marketing expenses, or administrative costs that outpaced the revenue growth. Without detailed information on the company's cost structure and expenses, it is challenging to provide a more precise analysis. However, it is clear that HIMS faced challenges in translating revenue growth into profitability during the quarter.